Mead Johnson Shares Crushed Amid Downgrades at Wells Fargo, Goldman Sachs

Loading...
Loading...
Shares of Mead Johnson Nutrition
MJN
are getting absolutely slammed Wednesday morning following several key downgrades earlier. A little more than an hour into the trading session, Mead Johnson shares are down 8.6 percent to $68.43. Wells Fargo analyst John Baumgartner lowered his investment rating on the stock from Outperform to Market Perform and reduced his 12-month valuation range from $87-89 to $76-78. Baumgartner believes Mead Johnson's China pricing investigation will be "financially manageable" despite the negative sentiment surrounding the inquiry. Baumgartner also pointed at tapering GDP growth in developing markets, resulting in elevated risk potential tied to inflation in dairy costs. Also weighing on Mead Johnson shares Wednesday morning is a downgrade from Buy to Neutral at Goldman Sachs.
Posted In: Analyst ColorNewsDowngradesAnalyst RatingsMovers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...